Clinical trial
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
NCT00000950 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000950 |
|---|---|
| Title | Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis |
| Official title | Pharmacokinetics of Antituberculosis Agents in HIV-Infected Persons With Tuberculosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | Ethambutol hydrochloride, Isoniazid, Pyrazinamide, Pyridoxine hydrochloride, Rifampin |
| Enrollment | 50 |
| Primary completion | May 1, 2002 |
| First posted | Aug 31, 2001 |
| Last update posted | Mar 2, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: